Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Samantha Teierle
Observed names:
Samantha M Teierle,
Samantha M. Teierle
Institutions:
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute,
The Ohio State University
Observed institutions:
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute,
The Ohio State University
ORCID:
0009-0004-0614-7924
Observed ORCID:
0009-0004-0614-7924
OpenAlex ID:
A5057989081
Characteristics and outcomes of patients with CLL and CDKN2A/B deletion by fluorescence in situ hybridization
2023
·
Samantha M. Teierle
, Ying Huang
, et al.
·
Blood Advances
·
7
PDF
CRISPR-Cas9-Mediated Correction of TSC2 Pathogenic Variants in iPSCs from Patients with Tuberous Sclerosis Complex Type 2
2024
·
Gongbo Guo
, Morgan Moser
, et al.
·
The CRISPR Journal
·
6
FISH Analysis of CDKN2A/B Deletion in Chronic Lymphocytic Leukemia
2022
·
Samantha M Teierle
, Ying Huang
, et al.
·
Blood
·
2
2: Artificial intelligence-assisted conventional chromosome analysis to explore clonal dynamics in chronic lymphocytic leukemia
2025
·
Matthew Avenarius
, Samantha Teierle
, et al.
·
Genetics in Medicine Open
·
1
PDF
Concurrent loss of TP53 and CDKN2A with tetraploidy predicts richter transformation and poor prognosis in chronic lymphocytic leukemia
2025
·
Anthony Mansour
, Ying Huang
, et al.
·
Blood
PDF
Loss of the Y chromosome defines a biologically distinct subtype of Acute Myeloid Leukemia (AML), associated with decreased inflammatory response patterns, and favorable outcomes in young male patients (pts)
2025
·
Maria Velegraki
, Cankun Wang
, et al.
·
Blood
Show more works
View as search
Works count:
6
Citation count:
16
H-index:
2
I10-index:
Year
Topic
Type